Neuroscientist Greg Gerdeman, PhD, one of the rare professors to teach the endocannabinoid system in college, challenges health professionals and researchers to study cannabis science and therapeutics.
The 2016 meeting of the International Cannabinoid Research Society focused on the latest research in cannabinoid studies and the endocannabinoid system.
A recent Care by Design survey of 300 patients suggests that cannabis is better than Big Pharma meds for PTSD issues.
Care By Design surveyed thousands of patients who had been using CBD-rich cannabis medicines for over 30 days. They asked patients what they were taking CBD-rich cannabis for, the ratio of CBD-to-THC they were using, and about its impact on pain, discomfort, energy, mood, and overall wellbeing.
Here’s what they learned: